Last reviewed · How we verify
NCT04607564
Pilot Study of the Ntombi Vimbela Sexual Violence Intervention Among Female Tertiary Students in South Africa
NA trial testing Ntombi Vimbela! intervention in Sexual Violence in 117 participants. Completed in 31 May 2021.
31 May 2021
Quick facts
| Lead sponsor | Medical Research Council, South Africa |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 117 |
| Start date | 23 August 2019 |
| Primary completion | 31 May 2021 |
| Estimated completion | 31 May 2021 |
| Sites | 6 locations across South Africa |
Drugs / interventions tested
- Ntombi Vimbela! intervention
Conditions studied
- Sexual Violence — all drugs for Sexual Violence →
Sponsor
Medical Research Council, South Africa
Who can join
Adults 18 to 30, female only, with Sexual Violence. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The pilot study aims to test the acceptability of content, feasibility of delivery methods and preliminary assessment of outcomes from the implementation of the Ntombi Vimbela intervention with volunteer groups of female first year students at eight South African higher education campuses. Data to inform the different objectives will be collected from participants at different time points. A baseline questionnaire was administered at the beginning of the Ntombi Vimbela workshops. Qualitative data to provide evidence about the workshop content and relevance was collected using participant end of workshop evaluation forms and end of intervention delivery focus group discussions.Feasibility data was collected through research team observations, facilitator debriefings and end of intervention delivery workshop One year post-implementation data which provides evidence of preliminary impact has commenced which includes a survey and in-depth interviews with participants.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Ntombi Vimbela! Sexual violence risk reduction intervention: pre and one-year post assessments from a single arm pilot feasibility study among female students in South Africa.
Machisa MT, Mahlangu P, Chirwa E, Nunze N, et al · · 2023 · cited 3× · PMID 37370055 · DOI 10.1186/s12889-023-16149-x
Verify or expand the search:
- PubMed search for NCT04607564
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Sexual Violence
Currently open trials in the same condition.
- NCT06746740 — Developing and Testing a Trauma-Informed Exercise Intervention for Women Veterans With Histories of Sexual Violence · NA · recruiting
- NCT06587529 — Rigorous Evaluation of the READY to Stand Curriculum to Prevent the Commercial Sexual Exploitation of Children · NA · recruiting
- NCT05873413 — Motivations, Attitudes, and Perceptions Study · NA · recruiting
- NCT06718387 — Evaluation of the Impact of Participation in a Psycho-education Program for Victims of Sexual Violence · NA · recruiting
Other Medical Research Council, South Africa trials
Trials by the same sponsor.
- NCT03448523 — Evaluation of Right To Play's Positive Child and Youth Development Program in Middle Schools in Hyderabad, Pakistan · NA · unknown
- NCT03477877 — Indashyikirwa IPV Prevention Trial in Rwanda · NA · completed
- NCT03237585 — Impact Assessment of the Rural Response System to Reduce Violence Against Women in Ghana · NA · unknown
- NCT02349321 — Skhokho Supporting Success: A Cluster RCT of a Multi-faceted, School-based IPV Prevention Intervention in South Africa · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04607564 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Medical Research Council, South Africa
- Last refreshed: 21 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04607564.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing